CReST

The CReST trial is looking at the role of endoluminal stenting in the acute management of obstructing colorectal cancer.

This trial was developed by the NCRI Colorectal Cancer Study Group and is funded by Cancer Research UK.

The chief investigators of the CReST trial are:
Professor Richard Gray, Director of BCTU
Mr Jim Hill, Consultant Surgeon, Manchester Royal Infirmary
Dr Clive Kay, Consultant Radiologist, Bradford Royal Infirmary

Primary objectives:

The primary objectives of the CReST RCT are to establish if endoluminal stenting for obstructing colonic cancers can result in:

• Reduced perioperative morbidity and reduced length of hospital stay.
• Reduced stoma formation,
• A measurable improvement in quality of life.

Recruitment

The trial aims to recruit 400 patients over 3 years.
There are currently 48 Centres open to recruitment. Recruitment of centres to the trial continues.

Registration Information

If you or your centre would like to participate then please download and complete the site registration form.

Please return the completed site registration form to the CReST Team at the following Freepost address:

CReST Trials Office,
FREEPOST RRKR-JUZR-HZHG,
Birmingham Clinical Trials Unit,
Division of Medical Sciences,
University of Birmingham,
Birmingham B15 2TT
FAX: +44 (0)121 415 8871

Alternatively you can contact the Birmingham Clinical Trials Unit:

Tel: 0121 415 9105
email: CreST@contacts.bham.ac.uk